View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 20, 2011

Pfizer launches biotech facility investment

Pfizer is to invest $200m to improve the company's biotechnology manufacturing plant in Clondalkin, County Dublin, Ireland.

By Liam Stoker

Pfizer is to invest $200m to improve the company’s biotechnology manufacturing plant in Clondalkin, County Dublin, Ireland.

The company’s Grange Castle facility will receive two new processing suites in order to expand its production and testing capacity, enhancing on the capabilities of what is already one of the world’s largest biotech facilities.

Pfizer CFO Frank D’Amelio noted that Ireland is a prime location for major investment, citing the fact that pharmaceutical and chemical products account for over 50% of Irish exports.

Pfizer currently produces two blockbuster products at the Grange Castle plant – pneumococcal disease vaccine Prevnar and arthritis medication Enbrel.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology